# LENALIDOMIDE
> **ANDA217554** · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2025-05-22
## Drug
- **FDA Application Number:** ANDA217554
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LENALIDOMIDE
- **Generic name:** LENALIDOMIDE
- **Active ingredients:** LENALIDOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** DEVA HOLDING AS
- **Manufacturer:** Devatis Inc.
- **First approval:** 2025-05-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217554)
---
*MORVS · CC0 1.0*